Why choose China for ICL EVO implantation?

China offers the procedure at a significantly lower cost (approximately $5,800 total) compared to many Western countries, without compromising on technology or safety. Chinese eye hospitals use the same FDA-approved EVO lenses and advanced diagnostic equipment as global centers. Many surgeons perform a high volume of ICL procedures annually, contributing to refined techniques and excellent outcomes. International patient services, including translation and coordination, are widely available.